NICE considers wider use of cancer sponge tests for indigestion patients
Health Desk
The National Institute for Health and Care Excellence (NICE) is evaluating the potential for more widespread use of sponge tests to assist patients suffering from severe indigestion. Currently, it is estimated that between one and two in every 100 adults have Barrett's oesophagus, a condition involving cellular changes that can occasionally lead to cancer.
Advertisement
Although most individuals with Barrett's oesophagus do not develop cancer, high demand for NHS endoscopies means that many patients are not monitored as frequently as medical guidelines advise. The proposed sponge test involves the patient swallowing a small dissolving capsule connected to a thread, which releases a tiny sponge once it reaches the stomach. A doctor then pulls the sponge back through the patient's mouth to collect cells from the gullet lining for analysis.
Prof Jonathan Benger, chief executive of NICE, described the method as a "quick and less invasive" way to spot concerning changes. He added that this approach helps identify those who require further medical investigation or treatment.
According to Prof Peter Johnson, national clinical director for cancer at NHS England, thousands have already used the test during pilot programmes. He stated: "The NHS is always looking for better ways to get to the bottom of people's symptoms, and thousands have already benefited from this incredibly efficient test through pilots we have been running, so it's fantastic it is now being considered for roll out across the country."
Prof Johnson further noted that the test could assist those with acid reflux by easing the need for more complex endoscopies, thereby allowing the NHS to allocate resources more effectively to detect cancers earlier. He added: "Many people have acid reflux, and having an easier way to check for changes in the lining of the oesophagus can make a big difference for patients, reducing the need for more complicated endoscopy tests and helping the NHS free up resources to find cancers at an earlier stage."
Advertisement
Despite these benefits, NICE cautioned that no diagnostic procedure is perfect. They advised that patients who receive a clear result from a sponge test should continue to be monitored in the long term. Final recommendations from the organisation are expected early in the new year.